Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
